SlideShare a Scribd company logo
Dr. Abhishek Tiwari,
Assistant Professor,
Department of Community Medicine,
Moti Lal Nehru Medical College, Prayagraj
Epidemiology,
Prevention &
Control of
Hypertension
Learning Objectives
To understand why Hypertension is a Public
Health Concern
To understand the Epidemiology of Hypertension
What all should be done to Prevent it ?
Methods available to Control Hypertension ?
11-10-2021
2
Introduction
Hypertension
or elevated blood
pressure - is a
serious medical
condition that
significantly
increases the risks
of heart, brain,
kidney and other
diseases.
11-10-2021
3
Introduction
An estimated 1.13 billion people worldwide have
HYPERTENSION, most of them (2/3rd) living in low &
middle-income countries.
Prevalence 30-40%, 24% in men & 20% women
Prevalence > 60% in people aged >60 years
In 2015, 1 in 4 men & 1 in 5 women had HTN
Annual increase of 15-20% estimated by 2025
A major cause of premature death worldwide.
One of the global targets for Noncommunicable
diseases is to reduce the prevalence of hypertension by
25% by 2025 (baseline 2010)
Burden - India
National Family Health Survey 2015-16
11% women and 15% in men were hypertensive
Prevalence was found to be higher in males and
those with high Body Mass Index.
Consistent increase in prevalence with increase in
BMI
Now – health & wellness center are focusing on
Noncommunicable Diseases and their prevention in
particular
Hypertension
Blood pressure is the force exerted by circulating blood
against the walls of the body’s arteries, the major blood
vessels in the body. Hypertension is when blood
pressure is too high.
The first (systolic) number represents the pressure in
blood vessels when the heart contracts or beats. The
second (diastolic) number represents the pressure in
the vessels when the heart rests between beats.
If on 2 different days, systolic BP readings on both
days is ≥140 mmHg and/or the diastolic BP readings on
both days is ≥90 mmHg only then we diagnose as HTN
Symptoms of HTN
Hypertension is called a "silent killer“
Most people with HTN are unaware of their status as
they have no warning signs or symptoms
It is essential to get blood pressure measured regularly.
When symptoms do occur, they are early morning
headaches, nosebleeds, irregular heart rhythms, vision
changes & buzzing in the ears
Severe hypertension can cause fatigue, nausea,
vomiting, confusion, anxiety, chest pain & muscle
tremors.
The only way to detect hypertension is to measure
Grading of HTN
Category Systolic (mm of
Hg)
Diastolic (mm
of Hg)
Optimal <120 And < 80
Normal 120 – 129 And/or 80 - 84
High Normal 130 – 139 And/or 85 - 89
Grade 1 HTN 140 – 159 And/or 90 - 99
Grade 2 HTN 160 – 179 And/or 100 - 109
Grade 3 HTN >= 180 And/or > 110
Isolated systolic HTN >= 140 And < 90
When systolic BP & diastolic BP readings fall in different
category, the higher category should be taken.
Higher the BP higher the risk of Cardiovascular disease.
Extent of organ damage varies in individuals with HTN, hence
it depends on many factors.
Measurement
Accurate measurement are essential under
STANDARDIZED conditions for valid comparisons
3 identified source of errors
a) Observer Error – Hearing acuity, interpretation of
korotkow sounds.
b) Instrumental error – e.g. leaking valves, cuffs not
encircling arm etc.
c) Subject errors – physical environment, position,
external stimuli such as fear, anxiety & so on
Sitting position is recommended and a uniform policy
of measurement is essential
Classification
Primary [Essential]
Cause unknown, accounts for 90% cases, most
common
Secondary
Some other disease process or abnormality
involved in causation, like kidney disease, adrenal
gland disorder, narrowing of Aorta, toxemia of
pregnancy, altogether less than 10% cases
Risk Factors of HTN
The “LIFESTYLE” disease has a range of risk factors
HTN is itself a major risk factor and it has its own risk
factors
NON MODIFIABLE
1) Age – BP increases with age in both sexes due to
accumulation of environmental factors and ageing
phenomenon
2) Sex – in adolescence Men display higher average,
difference is clearly evident in young & adults. Later
on this pattern narrows & may even reverse. Post
menopausal changes are contributory.
.
Risk Factors of HTN
NON MODIFIABLE
3) Genetic factors – evidence suggests BP levels are
determined partly by genetic factors, with
polygenic inheritance.
Twin studies - BP of monozygotic twins are strongly
related than zygotic twins. In contrast no relation
was found in levels of husband & wife, and between
adopted children.
Family studies – children of 2 normotensive parents
have 3% possibility of developing HTN, while it is
45% for hypertensive parents
.
Risk Factors of HTN
NON MODIFIABLE
4) Ethnicity – Population studies have shown higher
levels in black population
MODIFIABLE
1. OBESITY – Greater the wt. gain greater the risk.
On loosing weight the BP also decreases. “Central
obesity” has been positively correlated with high
BP
2. SALT INTAKE – high intake 7-8 g/day increases
the risk. Low sodium intake decreases the BP.
Japan sodium intake is above 400 mmol/day has
higher incidence
.
Risk Factors of HTN
3) SATURATED FAT – It raises BP & serum
cholesterol. Cholesterol & LDL are involved in
atherosclerosis.
Recommended – greater intake of PUFA and less
intake of saturated fat. Fat intake should be less than
30% of total calories.
4) DIETARY FIBRE – beneficial in reducing total
plasma total & LDL cholesterol.
5) ALCOHOL INTAKE – high intake is harmful
.
Risk Factors of HTN
6) HEART RATE – hypertensive subjects were found
to have higher heart rate. This may be due to
resetting of sympathetic activity at a higher level
7) PHYSICAL INACTIVITY – minimum of 30 minutes
for at least 5 days a week is essential to reduce
the risk of HTN and NCD. Sedentary lifestyle leads
to obesity and predisposes to NCD
8) ENVIRONMENTAL STRESS – higher noradrenaline
in hypertensive supports that over activity of
sympathetic system is involved
.
Risk Factors of HTN
9) SOCIO-ECONOMIC STATUS – earlier higher
disease burden in developed countries, but now
the trend is transitioning. More cases in low &
middle income countries.
10)OTHER FACTORS – most common cause of
secondary HTN is oral contraception, because of
oestrogen
.
Rule of Halves
Hypertension is an
“ICEBERG” Disease
Only 1/2 have been
diagnosed
Only 1/2 of those
diagnosed have been
treated
Only 1/2 of those
treated are adequately
controlled
Thus, only
12.5%overall are
adequately controlled
Tracking of Blood Pressure
If blood pressure of
individuals were followed up
over a period of years from
early childhood into adult
life, then those whose
pressures were initially high
in distribution, would
continue in the same “track”
as adults.
This phenomenon of
PERSISTENCE is called
tracking & can be applied in
identifying “AT RISK”
children & adolescents.
Causes of HTN
A
Prevention
WHO recommended approach:
1. Primary Prevention- “all measures to reduce the
incidence of disease in population by reducing
RISK of onset”
a. Population Strategy
b. High Risk Strategy
2. Secondary Prevention
We can control hypertension by medication
(secondary) but the ultimate goal is PRIMARY
Prevention 11-10-2021
20
Population Strategy- for All
Even a small reduction in average BP of Population
would produce large reduction in incidence of CVD
complications.
GOAL – to shift the BP
towards lower levels
with multifactorial
approach & non
Pharmacotherapeutic
interventions
11-10-2021
21
Interventions
Nutrition – DASH (dietary
approach to stop HTN), low
sodium & fat
Weight reduction – maintain
BMI < 25
Exercise promotion
Behavioural changes
Health Education
Self Care
High - Risk Strategy
GOAL – To prevent the attainment of levels of
blood pressure which requires treatment.
Appropriate for community with low prevalence of
risk factors
Detection of High RISK subjects by assessing all
predisposing factors & clinical methods
11-10-2021
22
Interventions to identify those at Higher RISK
Tracking of Blood Pressure from childhood
Family History details of hypertension
Secondary Prevention
GOAL – To detect & control high BP of effected
individual
1) Early Case detection – major problem, remember
silent killer and iceberg phenomenon. SCREENING
of population with adequate follow up
2) Treatment - modern Anti-hypertensive therapy
3) Patient compliance – “the extent to which the
patients behaviour coincides with clinical
prescription” . Health education improves
compliance
it’s a control and not cure so has to be LIFELONG
11-10-2021
23
Treatment
India
Hypertension
Management
Initiative (in
collaboration
with ICMR)
Measure BP of
all above 30
years
If SBP >= 140
and/or DBP >=
90 mm of Hg
then follow.
11-10-2021
24
Newer initiatives for NCD
Screening at all levels in the health care delivery
system from sub-centre & above
 Capacity building at various levels of health care for
prevention, early diagnosis, treatment, rehabilitation,
IEC/BCC, operational research and rehabilitation.
To support for development of database of NCDs
through Surveillance System and to monitor NCD
morbidity and mortality and risk factors.
Health promotion through behaviour change with
involvement of community, civil society, community
based organizations, media etc.
11-10-2021
25
Thank you all
11-10-2021
26

More Related Content

What's hot

IDSP- Integrated Disease Surveillance Programme
IDSP- Integrated Disease Surveillance ProgrammeIDSP- Integrated Disease Surveillance Programme
IDSP- Integrated Disease Surveillance Programme
Gaurav Kamboj
 
National programme for elderly final
National programme for elderly finalNational programme for elderly final
National programme for elderly finalMadhuri Bind
 
Malaria
MalariaMalaria
Malaria
Swati Singh
 
Lymphatic filariasis
Lymphatic filariasisLymphatic filariasis
Lymphatic filariasis
Dr.Hemant Kumar
 
Prevention of Hypertension
Prevention of Hypertension Prevention of Hypertension
Prevention of Hypertension
Dr Athar Khan
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
NTEP
NTEPNTEP
Diabetes
 Diabetes Diabetes
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
Dr Lipilekha Patnaik
 
Concepts of control & prevention of diseases
Concepts of control & prevention of diseasesConcepts of control & prevention of diseases
Concepts of control & prevention of diseases
Abdiwali Abdullahi Abdiwali
 
Hypertension Community Medicine Presentation
Hypertension Community Medicine PresentationHypertension Community Medicine Presentation
Hypertension Community Medicine Presentation
AdwaithA2
 
Concept of health and Disease
Concept of health and DiseaseConcept of health and Disease
Concept of health and Disease
Kailash Nagar
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
Dr. Ramesh Bhandari
 
Screening for Diseases
Screening for DiseasesScreening for Diseases
Screening for Diseases
Vishnu Yenganti
 
National leprosy eradication program
National leprosy eradication programNational leprosy eradication program
National leprosy eradication program
swati shikha
 
Acute respiratory infections
Acute respiratory infectionsAcute respiratory infections
Acute respiratory infections
Mallik Arjun D
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiology
Dr. Dharmendra Gahwai
 
Epidemiology of non-communicable disease
Epidemiology of non-communicable disease Epidemiology of non-communicable disease
Epidemiology of non-communicable disease
Kavya .
 
Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)
Prabesh Ghimire
 

What's hot (20)

IDSP- Integrated Disease Surveillance Programme
IDSP- Integrated Disease Surveillance ProgrammeIDSP- Integrated Disease Surveillance Programme
IDSP- Integrated Disease Surveillance Programme
 
National programme for elderly final
National programme for elderly finalNational programme for elderly final
National programme for elderly final
 
Malaria
MalariaMalaria
Malaria
 
Lymphatic filariasis
Lymphatic filariasisLymphatic filariasis
Lymphatic filariasis
 
Prevention of Hypertension
Prevention of Hypertension Prevention of Hypertension
Prevention of Hypertension
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
NTEP
NTEPNTEP
NTEP
 
Diabetes
 Diabetes Diabetes
Diabetes
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
 
Concepts of control & prevention of diseases
Concepts of control & prevention of diseasesConcepts of control & prevention of diseases
Concepts of control & prevention of diseases
 
Hypertension Community Medicine Presentation
Hypertension Community Medicine PresentationHypertension Community Medicine Presentation
Hypertension Community Medicine Presentation
 
Concept of health and Disease
Concept of health and DiseaseConcept of health and Disease
Concept of health and Disease
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Concept of health and disease
Concept of health and diseaseConcept of health and disease
Concept of health and disease
 
Screening for Diseases
Screening for DiseasesScreening for Diseases
Screening for Diseases
 
National leprosy eradication program
National leprosy eradication programNational leprosy eradication program
National leprosy eradication program
 
Acute respiratory infections
Acute respiratory infectionsAcute respiratory infections
Acute respiratory infections
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiology
 
Epidemiology of non-communicable disease
Epidemiology of non-communicable disease Epidemiology of non-communicable disease
Epidemiology of non-communicable disease
 
Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)
 

Similar to Epidemiology prevention control of hypertension

application of epidemiology in htn in community.pptx
application of epidemiology in htn in community.pptxapplication of epidemiology in htn in community.pptx
application of epidemiology in htn in community.pptx
anjalatchi
 
Non c d communti
Non c d communtiNon c d communti
Non c d communti
Bassam Daqaq
 
Hypertension
HypertensionHypertension
Hypertension
Shashikant Pawar
 
Hypertension
HypertensionHypertension
Hypertension
Sameen Rashid
 
Hypertension
HypertensionHypertension
Hypertension
yuyuricci
 
NPCDCS BY DR.R.MOHAN
NPCDCS  BY  DR.R.MOHANNPCDCS  BY  DR.R.MOHAN
NPCDCS BY DR.R.MOHAN
Dr.Ravindra Mohan
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
HPCareer.Net / State of Wellness Inc.
 
Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018
Monkez M Yousif
 
Hypertension by sourabh kosey
Hypertension by sourabh koseyHypertension by sourabh kosey
Hypertension by sourabh kosey
sopi_1234
 
Htn pharmacotherapy
Htn pharmacotherapyHtn pharmacotherapy
Htn pharmacotherapyDr P Deepak
 
Htn HYpertension
Htn HYpertensionHtn HYpertension
Htn HYpertension
manik chhabra.
 
Hypertension
HypertensionHypertension
Hypertension
ANANT NAG
 
Hypertension
HypertensionHypertension
HYPERTENSION IN COMMUNITY HEALTH NURSING
HYPERTENSION IN COMMUNITY HEALTH NURSINGHYPERTENSION IN COMMUNITY HEALTH NURSING
HYPERTENSION IN COMMUNITY HEALTH NURSING
Harsh Rastogi
 
Lecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in childrenLecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in children
Dr. Vithalrao Vikhe Patil Foundation's Medical College and Hospital, Ahmednagar
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathy
smita brahmachari
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1
monaaboserea
 
Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7semiologia
 

Similar to Epidemiology prevention control of hypertension (20)

application of epidemiology in htn in community.pptx
application of epidemiology in htn in community.pptxapplication of epidemiology in htn in community.pptx
application of epidemiology in htn in community.pptx
 
Non c d communti
Non c d communtiNon c d communti
Non c d communti
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
NPCDCS BY DR.R.MOHAN
NPCDCS  BY  DR.R.MOHANNPCDCS  BY  DR.R.MOHAN
NPCDCS BY DR.R.MOHAN
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
 
Hypertension management 2018
Hypertension management  2018Hypertension management  2018
Hypertension management 2018
 
Hypertension by sourabh kosey
Hypertension by sourabh koseyHypertension by sourabh kosey
Hypertension by sourabh kosey
 
Htn pharmacotherapy
Htn pharmacotherapyHtn pharmacotherapy
Htn pharmacotherapy
 
Htn HYpertension
Htn HYpertensionHtn HYpertension
Htn HYpertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
HYPERTENSION IN COMMUNITY HEALTH NURSING
HYPERTENSION IN COMMUNITY HEALTH NURSINGHYPERTENSION IN COMMUNITY HEALTH NURSING
HYPERTENSION IN COMMUNITY HEALTH NURSING
 
Lecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in childrenLecture-12. Prehypertension and hypertension in children
Lecture-12. Prehypertension and hypertension in children
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathy
 
HTN
HTNHTN
HTN
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1
 
Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7Hipertensão Arterial - Slides da JNC7
Hipertensão Arterial - Slides da JNC7
 
Joint National Committee
Joint National CommitteeJoint National Committee
Joint National Committee
 

More from Abhi Manu

The MODELS OF PUBLIC HEALTH.pptx
The MODELS OF PUBLIC HEALTH.pptxThe MODELS OF PUBLIC HEALTH.pptx
The MODELS OF PUBLIC HEALTH.pptx
Abhi Manu
 
HEALTH PROMOTION.pptx
HEALTH PROMOTION.pptxHEALTH PROMOTION.pptx
HEALTH PROMOTION.pptx
Abhi Manu
 
The Medical Termination of Pregnancy Act.pptx
The Medical Termination of Pregnancy Act.pptxThe Medical Termination of Pregnancy Act.pptx
The Medical Termination of Pregnancy Act.pptx
Abhi Manu
 
VITAMIN A.pptx
VITAMIN A.pptxVITAMIN A.pptx
VITAMIN A.pptx
Abhi Manu
 
METHODS OF COMMUNICATION.pptx
METHODS OF COMMUNICATION.pptxMETHODS OF COMMUNICATION.pptx
METHODS OF COMMUNICATION.pptx
Abhi Manu
 
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptxFOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
Abhi Manu
 
Health care delivary mln
Health care delivary mlnHealth care delivary mln
Health care delivary mln
Abhi Manu
 
Epidemiology, prevention &amp; control of rta
Epidemiology, prevention &amp; control of rtaEpidemiology, prevention &amp; control of rta
Epidemiology, prevention &amp; control of rta
Abhi Manu
 
Epidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hivEpidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hiv
Abhi Manu
 
Geriatric health
Geriatric healthGeriatric health
Geriatric health
Abhi Manu
 
Measles ELIMINATION
Measles ELIMINATIONMeasles ELIMINATION
Measles ELIMINATION
Abhi Manu
 
The standard normal curve & its application in biomedical sciences
The standard normal curve & its application in biomedical sciencesThe standard normal curve & its application in biomedical sciences
The standard normal curve & its application in biomedical sciencesAbhi Manu
 
Critical review of idsp
Critical review of idspCritical review of idsp
Critical review of idspAbhi Manu
 
Situational analysis in health care industry
Situational analysis in health care industrySituational analysis in health care industry
Situational analysis in health care industryAbhi Manu
 
Situational analysis in health care industry
Situational analysis in health care industrySituational analysis in health care industry
Situational analysis in health care industryAbhi Manu
 
critical review of RNTCP
critical review of RNTCPcritical review of RNTCP
critical review of RNTCPAbhi Manu
 

More from Abhi Manu (16)

The MODELS OF PUBLIC HEALTH.pptx
The MODELS OF PUBLIC HEALTH.pptxThe MODELS OF PUBLIC HEALTH.pptx
The MODELS OF PUBLIC HEALTH.pptx
 
HEALTH PROMOTION.pptx
HEALTH PROMOTION.pptxHEALTH PROMOTION.pptx
HEALTH PROMOTION.pptx
 
The Medical Termination of Pregnancy Act.pptx
The Medical Termination of Pregnancy Act.pptxThe Medical Termination of Pregnancy Act.pptx
The Medical Termination of Pregnancy Act.pptx
 
VITAMIN A.pptx
VITAMIN A.pptxVITAMIN A.pptx
VITAMIN A.pptx
 
METHODS OF COMMUNICATION.pptx
METHODS OF COMMUNICATION.pptxMETHODS OF COMMUNICATION.pptx
METHODS OF COMMUNICATION.pptx
 
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptxFOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
FOUNDATIONS OF COMMUNICATION 3 - Part 1.pptx
 
Health care delivary mln
Health care delivary mlnHealth care delivary mln
Health care delivary mln
 
Epidemiology, prevention &amp; control of rta
Epidemiology, prevention &amp; control of rtaEpidemiology, prevention &amp; control of rta
Epidemiology, prevention &amp; control of rta
 
Epidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hivEpidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hiv
 
Geriatric health
Geriatric healthGeriatric health
Geriatric health
 
Measles ELIMINATION
Measles ELIMINATIONMeasles ELIMINATION
Measles ELIMINATION
 
The standard normal curve & its application in biomedical sciences
The standard normal curve & its application in biomedical sciencesThe standard normal curve & its application in biomedical sciences
The standard normal curve & its application in biomedical sciences
 
Critical review of idsp
Critical review of idspCritical review of idsp
Critical review of idsp
 
Situational analysis in health care industry
Situational analysis in health care industrySituational analysis in health care industry
Situational analysis in health care industry
 
Situational analysis in health care industry
Situational analysis in health care industrySituational analysis in health care industry
Situational analysis in health care industry
 
critical review of RNTCP
critical review of RNTCPcritical review of RNTCP
critical review of RNTCP
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Epidemiology prevention control of hypertension

  • 1. Dr. Abhishek Tiwari, Assistant Professor, Department of Community Medicine, Moti Lal Nehru Medical College, Prayagraj Epidemiology, Prevention & Control of Hypertension
  • 2. Learning Objectives To understand why Hypertension is a Public Health Concern To understand the Epidemiology of Hypertension What all should be done to Prevent it ? Methods available to Control Hypertension ? 11-10-2021 2
  • 3. Introduction Hypertension or elevated blood pressure - is a serious medical condition that significantly increases the risks of heart, brain, kidney and other diseases. 11-10-2021 3
  • 4. Introduction An estimated 1.13 billion people worldwide have HYPERTENSION, most of them (2/3rd) living in low & middle-income countries. Prevalence 30-40%, 24% in men & 20% women Prevalence > 60% in people aged >60 years In 2015, 1 in 4 men & 1 in 5 women had HTN Annual increase of 15-20% estimated by 2025 A major cause of premature death worldwide. One of the global targets for Noncommunicable diseases is to reduce the prevalence of hypertension by 25% by 2025 (baseline 2010)
  • 5. Burden - India National Family Health Survey 2015-16 11% women and 15% in men were hypertensive Prevalence was found to be higher in males and those with high Body Mass Index. Consistent increase in prevalence with increase in BMI Now – health & wellness center are focusing on Noncommunicable Diseases and their prevention in particular
  • 6. Hypertension Blood pressure is the force exerted by circulating blood against the walls of the body’s arteries, the major blood vessels in the body. Hypertension is when blood pressure is too high. The first (systolic) number represents the pressure in blood vessels when the heart contracts or beats. The second (diastolic) number represents the pressure in the vessels when the heart rests between beats. If on 2 different days, systolic BP readings on both days is ≥140 mmHg and/or the diastolic BP readings on both days is ≥90 mmHg only then we diagnose as HTN
  • 7. Symptoms of HTN Hypertension is called a "silent killer“ Most people with HTN are unaware of their status as they have no warning signs or symptoms It is essential to get blood pressure measured regularly. When symptoms do occur, they are early morning headaches, nosebleeds, irregular heart rhythms, vision changes & buzzing in the ears Severe hypertension can cause fatigue, nausea, vomiting, confusion, anxiety, chest pain & muscle tremors. The only way to detect hypertension is to measure
  • 8. Grading of HTN Category Systolic (mm of Hg) Diastolic (mm of Hg) Optimal <120 And < 80 Normal 120 – 129 And/or 80 - 84 High Normal 130 – 139 And/or 85 - 89 Grade 1 HTN 140 – 159 And/or 90 - 99 Grade 2 HTN 160 – 179 And/or 100 - 109 Grade 3 HTN >= 180 And/or > 110 Isolated systolic HTN >= 140 And < 90 When systolic BP & diastolic BP readings fall in different category, the higher category should be taken. Higher the BP higher the risk of Cardiovascular disease. Extent of organ damage varies in individuals with HTN, hence it depends on many factors.
  • 9. Measurement Accurate measurement are essential under STANDARDIZED conditions for valid comparisons 3 identified source of errors a) Observer Error – Hearing acuity, interpretation of korotkow sounds. b) Instrumental error – e.g. leaking valves, cuffs not encircling arm etc. c) Subject errors – physical environment, position, external stimuli such as fear, anxiety & so on Sitting position is recommended and a uniform policy of measurement is essential
  • 10. Classification Primary [Essential] Cause unknown, accounts for 90% cases, most common Secondary Some other disease process or abnormality involved in causation, like kidney disease, adrenal gland disorder, narrowing of Aorta, toxemia of pregnancy, altogether less than 10% cases
  • 11. Risk Factors of HTN The “LIFESTYLE” disease has a range of risk factors HTN is itself a major risk factor and it has its own risk factors NON MODIFIABLE 1) Age – BP increases with age in both sexes due to accumulation of environmental factors and ageing phenomenon 2) Sex – in adolescence Men display higher average, difference is clearly evident in young & adults. Later on this pattern narrows & may even reverse. Post menopausal changes are contributory. .
  • 12. Risk Factors of HTN NON MODIFIABLE 3) Genetic factors – evidence suggests BP levels are determined partly by genetic factors, with polygenic inheritance. Twin studies - BP of monozygotic twins are strongly related than zygotic twins. In contrast no relation was found in levels of husband & wife, and between adopted children. Family studies – children of 2 normotensive parents have 3% possibility of developing HTN, while it is 45% for hypertensive parents .
  • 13. Risk Factors of HTN NON MODIFIABLE 4) Ethnicity – Population studies have shown higher levels in black population MODIFIABLE 1. OBESITY – Greater the wt. gain greater the risk. On loosing weight the BP also decreases. “Central obesity” has been positively correlated with high BP 2. SALT INTAKE – high intake 7-8 g/day increases the risk. Low sodium intake decreases the BP. Japan sodium intake is above 400 mmol/day has higher incidence .
  • 14. Risk Factors of HTN 3) SATURATED FAT – It raises BP & serum cholesterol. Cholesterol & LDL are involved in atherosclerosis. Recommended – greater intake of PUFA and less intake of saturated fat. Fat intake should be less than 30% of total calories. 4) DIETARY FIBRE – beneficial in reducing total plasma total & LDL cholesterol. 5) ALCOHOL INTAKE – high intake is harmful .
  • 15. Risk Factors of HTN 6) HEART RATE – hypertensive subjects were found to have higher heart rate. This may be due to resetting of sympathetic activity at a higher level 7) PHYSICAL INACTIVITY – minimum of 30 minutes for at least 5 days a week is essential to reduce the risk of HTN and NCD. Sedentary lifestyle leads to obesity and predisposes to NCD 8) ENVIRONMENTAL STRESS – higher noradrenaline in hypertensive supports that over activity of sympathetic system is involved .
  • 16. Risk Factors of HTN 9) SOCIO-ECONOMIC STATUS – earlier higher disease burden in developed countries, but now the trend is transitioning. More cases in low & middle income countries. 10)OTHER FACTORS – most common cause of secondary HTN is oral contraception, because of oestrogen .
  • 17. Rule of Halves Hypertension is an “ICEBERG” Disease Only 1/2 have been diagnosed Only 1/2 of those diagnosed have been treated Only 1/2 of those treated are adequately controlled Thus, only 12.5%overall are adequately controlled
  • 18. Tracking of Blood Pressure If blood pressure of individuals were followed up over a period of years from early childhood into adult life, then those whose pressures were initially high in distribution, would continue in the same “track” as adults. This phenomenon of PERSISTENCE is called tracking & can be applied in identifying “AT RISK” children & adolescents.
  • 20. Prevention WHO recommended approach: 1. Primary Prevention- “all measures to reduce the incidence of disease in population by reducing RISK of onset” a. Population Strategy b. High Risk Strategy 2. Secondary Prevention We can control hypertension by medication (secondary) but the ultimate goal is PRIMARY Prevention 11-10-2021 20
  • 21. Population Strategy- for All Even a small reduction in average BP of Population would produce large reduction in incidence of CVD complications. GOAL – to shift the BP towards lower levels with multifactorial approach & non Pharmacotherapeutic interventions 11-10-2021 21 Interventions Nutrition – DASH (dietary approach to stop HTN), low sodium & fat Weight reduction – maintain BMI < 25 Exercise promotion Behavioural changes Health Education Self Care
  • 22. High - Risk Strategy GOAL – To prevent the attainment of levels of blood pressure which requires treatment. Appropriate for community with low prevalence of risk factors Detection of High RISK subjects by assessing all predisposing factors & clinical methods 11-10-2021 22 Interventions to identify those at Higher RISK Tracking of Blood Pressure from childhood Family History details of hypertension
  • 23. Secondary Prevention GOAL – To detect & control high BP of effected individual 1) Early Case detection – major problem, remember silent killer and iceberg phenomenon. SCREENING of population with adequate follow up 2) Treatment - modern Anti-hypertensive therapy 3) Patient compliance – “the extent to which the patients behaviour coincides with clinical prescription” . Health education improves compliance it’s a control and not cure so has to be LIFELONG 11-10-2021 23
  • 24. Treatment India Hypertension Management Initiative (in collaboration with ICMR) Measure BP of all above 30 years If SBP >= 140 and/or DBP >= 90 mm of Hg then follow. 11-10-2021 24
  • 25. Newer initiatives for NCD Screening at all levels in the health care delivery system from sub-centre & above  Capacity building at various levels of health care for prevention, early diagnosis, treatment, rehabilitation, IEC/BCC, operational research and rehabilitation. To support for development of database of NCDs through Surveillance System and to monitor NCD morbidity and mortality and risk factors. Health promotion through behaviour change with involvement of community, civil society, community based organizations, media etc. 11-10-2021 25